An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis-Reference-Cited by-同舟云学术

An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis

Published:2023-12 Issue: Volume: Page:
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Snijders Romée J.A.L.M.^ORCID,Stoelinga Anna E.C.^ORCID,Gevers Tom J.G.^ORCID,Pape Simon^ORCID,Biewenga Maaike,Tushuizen Maarten E.^ORCID,Verdonk Robert C.^ORCID,de Jonge Hendrik J.M.,Vrolijk Jan Maarten,Bakker Sjoerd F.,Vanwolleghem Thomas^ORCID,de Boer Ynto S.^ORCID,Baven Pronk Martine A.M.C.,Beuers Ulrich,van der Meer Adriaan J.^ORCID,Gerven Nicole M.F. van,Sijtsma Marijn G.M.^ORCID,van Eijck Brechje C.,van IJzendoorn Manon C.,van Herwaarden Margot^ORCID,van den Brand Floris F.^ORCID,Korkmaz Kerem Sebib,van den Berg Aad P.^ORCID,Guichelaar Maureen M.J.,Levens Amar D.^ORCID,van Hoek Bart^ORCID,Drenth Joost P.H.

Funder

Fonds Wetenschappelijk Onderzoek

Chiesi Farmaceutici

ZonMw

Publisher

Elsevier BV

Subject

Hepatology

Reference49 articles.

1. Systematic review and meta-analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population;Lv;J Gastroenterol Hepatol,2019

2. EASL clinical practice guidelines: autoimmune hepatitis;J Hepatol,2015

3. Second-line and third-line therapy for autoimmune hepatitis: a position statement from the European reference Network on hepatological diseases and the international autoimmune hepatitis group;Lohse;J Hepatol,2020